Results 101 to 110 of about 88,264 (269)
Supplemental material, sj-jpg-2-cll-10.1177_09636897231198178 for Haploidentical Natural Killer Cell Therapy as an Adjunct to Stem Cell Transplantation for Treatment of Refractory Acute Myeloid Leukemia by Uday Kulkarni, Arun Kumar Arunachalam, Hamenth ...
Arun Kumar Arunachalam (16630276) +13 more
core +1 more source
We present cryoBN‐PAGE, a method that enables blue native polyacrylamide gel electrophoresis analysis of mitochondrial respiratory complexes and supercomplexes directly from whole yeast cells using cryogenic milling. This approach eliminates the need for mitochondrial isolation, reducing time and cost while preserving native protein complexes.
Lizeth J. Camacho Lopez +3 more
wiley +1 more source
The regulatory capacity of B cells directs the aggressiveness of CLL
Chronic lymphocytic leukemia (CLL) is associated with abnormal T-cell responses responsible for defective anti-tumor activities. Intriguingly, CLL B cells share phenotypical characteristics with regulatory B (Breg) cells suggesting that they might ...
Audrey Mohr +12 more
doaj +1 more source
Supplemental material, sj-docx-1-cll-10.1177_09636897241226546 for Effect of High BMI on Human Bone Marrow–Derived Mesenchymal Stromal Cells by Qiang Zong, Katrin Bundkirchen, Claudia Neunaber and Sandra Noack in Cell ...
Claudia Neunaber (325608) +3 more
core +1 more source
În literatura de specialitate sunt prezentate foarte puține cazuri de leucemie limfocitară cronică (LLC), care debutează cu hiperleucocitoză extremă. Descriem cazul unei femei în vârstă de 66 ani, care se prezintă cu hiperleucocitoză extremă de 774.2 x ...
Bacârea Anca +4 more
doaj +1 more source
ABSTRACT Introduction Gender‐affirming hormone therapy (GAHT) may be associated with increased cardiometabolic disease (CMD) risk. Prospective CMD risk screening is recommended, but long‐term data are needed regarding changes in CMD markers. Objectives To evaluate prospective changes in CMD risk markers during GAHT.
Louise Lehmann Christensen +7 more
wiley +1 more source
The expression BIRC6 gene in patients with chronic lymphocytic leukemia – a preliminary study
The BIRC6 gene encodes the Bruce (Apollon) protein. This belongs to the III class of Inhibitors of the Apoptosis Protein (IAP) and demonstrates anti-apoptotic activity (binding, inhibiting and degrading the caspases).
Chomik Piotr +12 more
doaj +1 more source
Splenectomy is a safe and effective treatment option in selected patients with haematological disease, despite declining referrals over the last 27 years in the era of targeted therapies. Outcomes are favourable when performed laparoscopically and long‐term follow‐up demonstrates sustained haematologic benefit in surviving patients.
Salil Dutt Barrett +9 more
wiley +1 more source
From solid organ malignancies to dual leukaemias: sequential CLL and CML in a cancer survivor
Introduction: Chronic lymphocytic leukaemia (CLL), the most common adult leukaemia is known to undergo Richter’s transformation. However, transformation into myeloid neoplasms is extremely rare with no established pathogenetic mechanisms.
Sukhmani Sidhu +2 more
doaj +1 more source
Mosaic chromosomal alterations and relation to haematological cancer in two large Danish cohorts
Summary Mosaic chromosomal alterations (mCAs) are large somatic gains, losses and copy‐neutral loss of heterozygosity identified in the peripheral blood, which represent a relatively unexplored spectrum of clonal haematopoiesis. We aimed to describe mCAs in two large Danish cohorts with extensive long‐term registry‐based follow‐up and examine ...
Cecilie Velsoe Maeng +23 more
wiley +1 more source

